The Jakarta Post
The first dengue vaccine has arrived in Indonesia, bringing hopes of curbing one of the most challenging diseases in the country.
The vaccine, named Dengxavia, is a result of 20 years of research and experiments by Sanofi Pasteur, the world’s largest vaccine producer.
The World Health Organization (WHO) has endorsed the vaccine, saying that it represents a major step in controlling the disease as there is no established cure for dengue fever currently, which can cause severe nausea, bone pain, headaches, rashes, bleeding and even death.
Mexico was the first country in the world to register the vaccine in December last year and was quickly followed by 11 other countries, including Brazil, Indonesia, Singapore, Thailand and the Philippines, all countries with a high endemic rate of dengue fever.
Ongoing clinical trials in Indonesia, which started in 2011 and ...